Trial NCT03173963

View at ClinicalTrials.gov 
Org. Study IDs: 999917103
Secondary IDs: 17-DK-N103

Last trial update was posted on 2020-02-25

MeSH Interventions

Empagliflozin

MeSH Conditions

Diabetes Mellitus, Type 2 Diabetic Nephropathies Kidney Diseases

Other Conditions

Diabetes Mellitus Type 2 Diabetic Kidney Disease

Stopping Reasons

Original drug sponsor withdrew from study, replacement sponsor not obtained.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID